Journal article
Utility of different adherence measures for PrEP: Patterns and incremental value
- Abstract:
-
Measuring PrEP adherence remains challenging. In 2009-2010, the International AIDS Vaccine Initiative randomized phase II trial participants to daily tenofovir disoproxil fumarate/emtricitabine or placebo in Uganda and Kenya. Adherence was measured by electronic monitoring (EM), self-report (SR), and drug concentrations in plasma and hair. Each adherence measure was categorised as low, moderate, or high and also considered continuously; the incremental value of combining measures was determin...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Springer Publisher's website
- Journal:
- AIDS and Behavior Journal website
- Volume:
- 22
- Issue:
- 4
- Pages:
- 1165-1173
- Publication date:
- 2017-10-31
- DOI:
- EISSN:
-
1573-3254
- ISSN:
-
1090-7165
- Pmid:
-
29090394
- Source identifiers:
-
742528
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:742528
- UUID:
-
uuid:ee6df746-8593-43eb-9c51-afe754777a3c
- Local pid:
- pubs:742528
- Deposit date:
- 2018-04-17
Terms of use
- Copyright holder:
- Sanders et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record